Literature DB >> 3404228

Management of elderly patients with aneurysmal subarachnoid hemorrhage.

T Inagawa1, M Yamamoto, K Kamiya, H Ogasawara.   

Abstract

A total of 299 patients with aneurysmal subarachnoid hemorrhage (SAH) were classified into three age groups, that is, those aged 59 years or younger (Group 1: 159 patients, 53%), those aged 60 to 69 years (Group 2: 85 patients, 28%), and those aged 70 years or older (Group 3: 55 patients, 18%). A comparison was made of the surgical indications and their overall management outcome in these age groups. The overall outcome at 1 year after SAH of Group 3 was significantly poorer than that of Group 1 (p less than 0.01) or Group 2 (p less than 0.01), but no significant difference could be demonstrated between Groups 1 and 2. Overall, 104 of the 299 patients died, for a mortality rate of 35%. The mortality rate by age group was 29% for Group 1, 33% for Group 2, and 55% for Group 3. Surgery was performed on 122 patients (77%) in Group 1, 56 (66%) in Group 2, and 25 (45%) in Group 3. The overall operative outcome at 1 year after SAH in Group 3 was significantly poorer than that of Group 1 (p less than 0.01), but no significant difference was observed in this regard between Groups 1 and 2. The operative mortality rate of the patients in Groups 1, 2, and 3 who were preoperatively in Hunt and Hess Grades I and II was 1%, 7%, and 22%, respectively (no significant difference). By life-table analysis the 5-year survival probability was 65% for Group 1, 60% for Group 2, and 37% for Group 3. The rate of patients surviving in good condition or in a disabled but independent condition at 1 year after SAH was 93% and no statistically significant difference in survival probability was observed among the three age groups.

Entities:  

Mesh:

Year:  1988        PMID: 3404228     DOI: 10.3171/jns.1988.69.3.0332

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

Review 1.  Ruptured intracranial aneurysms in the elderly: epidemiology, diagnosis, and management.

Authors:  Jacques Sedat; Mustapha Dib; David Rasendrarijao; Denys Fontaine; Michel Lonjon; Philippe Paquis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Surgical treatment of multiple intracranial aneurysms.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Pre- and post-operative cerebral blood flow changes in subarachnoid haemorrhage.

Authors:  J M Mountz; J E McGillicuddy; M W Wilson; S P Bartold; E M Siegal
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Effect of ultra-early referral on management outcome in subarachnoid haemorrhage.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  Endovascular treatment for unruptured intracranial aneurysms in elderly patients: single-center report.

Authors:  S-K Hwang; G Hwang; C W Oh; S-C Jin; H Park; J S Bang; O-K Kwon
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-19       Impact factor: 3.825

6.  Cerebral vasospasm in elderly patients treated by early operation for ruptured intracranial aneurysms.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 7.  Prevalence of cerebral aneurysms in autopsy studies: a review of the literature.

Authors:  Tetsuji Inagawa
Journal:  Neurosurg Rev       Date:  2022-04-22       Impact factor: 2.800

8.  Effect of continuous cisternal drainage on cerebral vasospasm.

Authors:  T Inagawa; K Kamiya; Y Matsuda
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

9.  Multiple intracranial aneurysms in elderly patients.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

10.  Treatment results of endosaccular coil embolization of asymptomatic unruptured intracranial aneurysms in elderly patients.

Authors:  Hidenori Oishi; Munetaka Yamamoto; Senshu Nonaka; Takashi Shimizu; Kensaku Yoshida; Takashi Mitsuhashi; Hajime Arai
Journal:  J Neurointerv Surg       Date:  2014-07-17       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.